XNK Therapeutics presented two posters at the NK2023 conference in Oslo

XNK Therapeutics AB announced that two posters, regarding bladder cancer and acute myeloid leukemia respectively, was presented at the 20th Meeting of the Society for Natural Immunity in Oslo, Norway, in September.

Scroll to Top